Title: Christopher Semko, et al. Rapamycin analogs as mtor inhibitors. WO2018204416A1.
185022-12-2
54149-41-6
93460-33-4
1820607-95-1 | 2-(Benzyloxy)-4-chloro-1-iodobenzene | AA00I0EX | MFCD27981315
1820650-73-4 | 2-(4-Methoxybenzylamino)-5-nitrobenzaldehyde | AA00I0MF | MFCD28014035
1820704-68-4 | 5-Bromo-3-acetamidopyridine-2-carboxylic acid | AA00I0U6 | MFCD26383425
1820741-36-3 | 2-(N-Ethyl-N-methanesulfonyl)amino-3-nitropyridine | AA00I11Y | MFCD28369602
1824298-38-5 | (2-Ethynylpyridin-3-yl)methanol | AA00I1AV | MFCD22192201
18524-94-2 | Loganin | AA00I1GS | MFCD00075645
187942-05-8 | Benzoic acid, 4-chloro-2-[(chloroacetyl)amino]- | AA00I1TG | MFCD03980979
1909317-09-4 | 1-(Aminomethyl)cyclopentanecarbonitrile hydrochloride | AA00I2QZ | MFCD27997393
1951424-95-5 | (2S,4S)-4-Fluoro-2-(fluoromethyl)pyrrolidine hydrochloride | AA00I30W | MFCD28119072
195433-53-5 | N-(2-Nitrophenyl)-N-propylmethanesulfonamide | AA00I3B2 | MFCD28122687
